Register

COURSE DESCRIPTION:  

Twenty years ago, following the September 11 attacks, the United States suffered a premeditated act of bioterrorism. With the postal service as a resource, anthrax spores were widely spread from coast to coast, leading to morbidity and mortality and successfully disrupting our way of life and revealing our vulnerability. To address the question of whether we as a nation are now better prepared for future threats involving biologic agents, Dr. Bush will discuss the lessons learned from the 2001 anthrax attacks as well as the critical role of clinicians in surveillance particularly those involved in diagnosing anthrax in individuals and alerting authorities. 

TARGET AUDIENCE:

Internal Medicine Physicians, Physician Assistants, Residents,  Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers. 

LEARNING OBJECTIVES:

• Review and discuss Class ‘A’ CDC List of bioterrorism agents.
• Recognize, diagnose, and treat anthrax.
• Discuss the Who, What, and Where of USA bioterrorism.
   

FACULTY AND DISCLOSURES:

Larry M. Bush, M.D., FACP, FIDSA
Affiliate Clinical Professor of Medicine
Charles E. Schmidt College of Medicine
Florida Atlantic University
Affiliate Associate Professor of Medicine
Department of Medical Education
University of Miami-Miller School of Medicine
Regional Campus
Palm Beach, Florida 

Larry M. Bush, M.D., FACP, FIDSA, faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.